ToPCaP

Who We Are

ToPCaP (Transdisciplinary Prostate Cancer Partnership) is an international, multi-disciplined, organized consortium of prostate cancer researchers with access to a unique combination of facilities, data, biobanks and equipment that are pursuing the most urgent prostate cancer questions.

University of Iceland Reykjavik, Iceland University College Dublin (UCD) Dublin, Ireland Trinity College Dublin (TCD) Dublin, Ireland Örebro University Örebro, Sweden National University of Ireland (NUI), Galway Galway, Ireland Memorial Sloan Kettering Cancer Center New York, NY, USA Mayo Clinic Rochester, MN USA King's Health Partners London, England King's College London London, England Karolinska Institutet Stockholm, Sweden Harvard T.H. Chan School of Public Health Boston, MA USA Dana-Farber Cancer Institute / Brigham and Women's Hospital Boston, MA USA Bologna University Hospital Authority St. Orsola-Malpighi Polyclinic Bologna, Italy

Recent News

ToPCaP Researchers Receive Funding from National Institutes of Health to Study Impact of Circadian Rhythm and Prostate Cancer Risk

ToPCaP Researchers Receive Funding from National Institutes of Health to Study Impact of Circadian Rhythm and Prostate Cancer Risk

February 5, 2016

Read More »

View All >
Finn

Featured Researcher

Stephen Finn - Dr. Stephen Finn is an academic Histopathologist with subspecialist interests limited to genitourinary pathology and cancer molecular diagnostics.

Infection and inflammation in prostate cancer

Featured
Project

Infection and inflammation in prostate cancer - Approximately 20% of all human cancers are assumed to be a result from infection and chronic inflammation and a classical example...